ACE2 and COVID-19: One explanation for the paradox has been that because ACE2 is a cardioprotective enzyme, while ACE2 is the receptor for airway infection of SARS-CoV-2, low levels of ACE2 in the circulation of elderly patients and those with cardiovascular disease increase the risk for cardiovascular complications associated with severe COVID-19 (45).